merck

Welcome to the 'merck' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'merck'.

Latest blogosphere posts tagged “merck”

• Vytorin – print ad

  
  AdPharm Blog — Authority: 148
  There are 2 sources of cholesterol. Food & Family. Only Vytorin treats both Read the rest on AdPharms blog!
  9 hours ago

• Aegis Rolls out Latest Version of Discoverant

  
  Pharmainfo.net — Authority: 169
  Aegis Rolls out Latest Version of Discoverant Trading Markets - 50 minutes ago Nov 20, 2009 (Close-Up Media via COMTEX) -- MRK -- Aegis Analytical, a provider of Enterprise Manufacturing Intelligence (EMI) software solutions, announced the release of Discoverant 3.4, the ... Advertisement: read more
  18 hours ago

• EU approves Merck takeover of Schering-Plough

  
  Pharmainfo.net — Authority: 169
  EU approves Merck takeover of Schering-Plough Linex Legal - 27 minutes ago Source: LexisNexis - BRUSSELS – (AP) The European Union approved Merck & Co.s proposed takeover of Schering-Plough, which would create the second-biggest global producer of prescription medicines ... Advertisement: read more
  1 day ago

• Ligand receives US$ 2 mn milestone payments from Merck for research pact

  
  Pharmainfo.net — Authority: 169
  Ligand receives US$ 2 mn milestone payments from Merck for research pact pharmabiz.com - 16 minutes ago Ligand Pharmaceuticals Incorporated has received US$ 2 million in milestone payments from NV Organon, a subsidiary of Merck & Co, Inc, stemming from its research collaboration that is due to ... ...
  1 day ago

• Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions

  
  Pharmainfo.net — Authority: 169
  Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions Trading Markets - 41 minutes ago Nov 21, 2009 (Close-Up Media via COMTEX) -- MRK -- In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co ... ...
  1 day ago

• Stocks That Will Continue to Achieve New Highs (BBY, SJM, AGU, KO, TRA, MRK, CTL)

  
  Pharmainfo.net — Authority: 169
  Stocks That Will Continue to Achieve New Highs (BBY, SJM, AGU, KO, TRA, MRK, CTL) Advertisement: read more
  2 days ago

• Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE

  
  Pharmainfo.net — Authority: 169
  Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE Wall Street Journal - 50 minutes ago By Peter Loftus Of DOW JONES NEWSWIRES Several US pharmaceutical stocks rose Friday as Pfizer Inc. (PFE) and Merck & Co. (MRK) hit 52-week highs, partly due to increasing investor comfort that a ... ...
  2 days ago

• Stocks on the move: Consol, Dell, Leap, LogMeIn, Merck, Novavax

  
  Pharmainfo.net — Authority: 169
  Stocks on the move: Consol, Dell, Leap, LogMeIn, Merck, Novavax Tri-Valley Herald - 1 hour ago By Lu Wang ADC Telecommunications Inc. (ADCT US) had the steepest decline in Russell 2000 Index, losing 15 percent to $5.64. The maker of equipment for telephone companies forecast first- quarter ... Advertisement: ...
  2 days ago

• 4-Star Stocks Poised to Pop: Merck

  
  Pharmainfo.net — Authority: 169
  4-Star Stocks Poised to Pop: Merck Motley Fool - 7 minutes ago By Brian D. Pacampara Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS, the Fools free investing community, drug behemoth Merck (NYSE: MRK) has ... Advertisement: read more
  2 days ago

• Ligand wins $2 million milestone payments from NV Organon

  
  Pharmainfo.net — Authority: 169
  Ligand wins $2 million milestone payments from NV Organon Trading Markets - 5 minutes ago Nov 20, 2009 (Datamonitor via COMTEX) -- MRK -- Ligand Pharmaceuticals has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co, stemming from its research ... Advertisement: read ...
  2 days ago

• Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst

  
  Pharmainfo.net — Authority: 169
  Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Advertisement: read more
  2 days ago

• Merck & Co., Inc. Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA

  
  Pharmainfo.net — Authority: 169
  Merck & Co., Inc. Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA Reuters Key Development - 58 minutes ago Advertisement: read more
  2 days ago

• Pharmalot… Pharmalittle… The Weekend Nears

  
  Pharmalot — Authority: 584
  Once again, the week is about to draw to a close. And not a moment too soon. Of course, we must still muddle through another deadline or meeting, but relief is in sight. What will you do this weekend? We will, of course, rake more leaves and spend time with assorted short people. With any luck, we may also read a ...
  2 days ago

• Glaxo, Merck developing drugs for kala azar

  
  Pharmainfo.net — Authority: 169
  Glaxo, Merck developing drugs for kala azar DNA India - 23 minutes ago Heard of kala azar or leishmaniasis? Chances are you havent. Amid cancer, diabetes, strokes, flu, arthritis, etc, this life threatening disease, which affects millions of poor people in the world ... Advertisement: read more
  3 days ago

• Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low

  
  Pharmainfo.net — Authority: 169
  Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low Advertisement: read more
  3 days ago

• Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG,...

  
  Business Finance & Economy - business.marc8.com — Authority: 166
  Notable 52-week Highs on the NYSE: Cardinal Health, Inc. (NYSE: CAH) - Hit $31.77. UBS initiated coverage with a Buy rating on Cardinal. Donaldson Company Inc. (NYSE: DCI) - touched $45.09. The company reported Q110 earnings about the Street estimates today. IMS Health Inc. (NYSE: RX) - reached $21.65 King ...
  3 days ago

• NEWS | SAN DIEGO Ligand earns $2 million in milestone payments from Merck

  
  Pharmainfo.net — Authority: 169
  NEWS | SAN DIEGO Ligand earns $2 million in milestone payments from Merck San Diego Daily Transcript - 1 hour ago Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co. Inc. (NYSE: MRK), stemming from its research collaboration ... ...
  3 days ago

• Incorporated - Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.

  
  Pharmainfo.net — Authority: 169
  Incorporated - Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc. Advertisement: read more
  3 days ago

• Ligand Nabs $2M From Merck

  
  Xconomy — Authority: 712
  Biotech , deals , Life Sciences Luke Timmerman wrote: San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later ...
  3 days ago

• Applied Materials, Merck and Braunschweig University awarded funding

  
  Pharmainfo.net — Authority: 169
  Applied Materials, Merck and Braunschweig University awarded funding Advertisement: read more
  3 days ago

Comments about merck